2 days Zacks Research Comments on ACADIA Pharmaceuticals Inc.’s Q3 2025 Earnings (NASDAQ:ACAD)MarketBeat
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Zacks Research boosted their Q3 2025 earnings estimates for shares of ACADIA Pharmaceuticals in a research report issued on Wednesday, October 9th. Zacks Research analyst A. Chakraborty now e…
Earnings · Nasdaq 100 · Pharmaceuticals · Science
X